123 related articles for article (PubMed ID: 38469839)
1. Color Doppler Ultrasound Indices as Predictors of Propranolol Response in Infantile Hemangioma: A Prospective Study.
Pandey V; Bera RN; Diwedi AND; Singh OP; Tiwari P
Indian Pediatr; 2024 Mar; 61(3):237-242. PubMed ID: 38469839
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin-triamcinolone sclerotherapy in the management of propranolol resistant infantile hemangioma of the maxillofacial region: A single arm prospective evaluation of clinical outcome and Doppler ultrasound parameters.
Tiwari P; Bera RN; Pandey V
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1S):101313. PubMed ID: 36261060
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Radiological Evaluation of Periocular Infantile Hemangioma Treated With Oral Propranolol: A Case Series.
Ginguerra MA; Saito O; Fernandes JBVD; Castro DS; Matayoshi S
Am J Ophthalmol; 2018 Jan; 185():48-55. PubMed ID: 29103963
[TBL] [Abstract][Full Text] [Related]
4. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Ultrasonographic Evaluation of Infantile Periocular Hemangioma Treated With Oral Propranolol.
Jamshidian-Tehrani M; Nabavi A; Taghavi M; Sharif-Kashani S; Kasaee A; Sadeghi-Tari A; Mirhosseini M; Nowroozzadeh MH
Ophthalmic Plast Reconstr Surg; 2019; 35(5):484-486. PubMed ID: 30844918
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
7. Is Propranolol Safe and Effective for Outpatient Use for Infantile Hemangioma? A Prospective Study of 679 Cases From One Center in China.
Chang L; Ye X; Qiu Y; Ma G; Jin Y; Chen H; Lv D; Yu W; Yang X; Wang T; Lin X
Ann Plast Surg; 2016 May; 76(5):559-63. PubMed ID: 26101993
[TBL] [Abstract][Full Text] [Related]
8. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Results of Oral Propranolol Treatment Protocol for Periocular Infantile Hemangioma: Should There Be Any Contraindication?
Ghahvehchian H; Kashkouli MB; Ghanbari S; Karimi N; Abdolalizadeh P; Abri Aghdam K
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):61-69. PubMed ID: 38241619
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
11. Adverse Drug Reactions Following Propranolol in Infantile Hemangioma.
Pandey V; Tiwari P; Imran M; Mishra A; Kumar D; Sharma SP
Indian Pediatr; 2021 Aug; 58(8):753-755. PubMed ID: 34465658
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
[TBL] [Abstract][Full Text] [Related]
13. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Vassallo P; Forte R; Di Mezza A; Magli A
Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
[TBL] [Abstract][Full Text] [Related]
14. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
[TBL] [Abstract][Full Text] [Related]
15. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
He L; Huang G
J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study.
Wang L; Wang W; Zhou Z; Li J; Li Z; Lv R; Xu G; Bi J; Huo R
J Am Acad Dermatol; 2024 Apr; 90(4):783-789. PubMed ID: 38159645
[TBL] [Abstract][Full Text] [Related]
18. Cardiac side effects of propranolol in infants treated for infantile haemangiomas.
Maliqari N; Duka E; Kuneshka L
Cardiol Young; 2023 Dec; 33(12):2616-2620. PubMed ID: 37078179
[TBL] [Abstract][Full Text] [Related]
19. Monitoring oral propranolol for infantile hemangiomata.
Bar J; Bar-Ilan E; Cleper R; Sprecher E; Samuelov L; Mashiah J
Dermatol Ther; 2022 Nov; 35(11):e15870. PubMed ID: 36177767
[TBL] [Abstract][Full Text] [Related]
20. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study.
Bertrand J; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Powell J
Pediatr Dermatol; 2011; 28(6):649-654. PubMed ID: 21995756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]